McLaren drivers Lando Norris and Oscar Piastri have been disqualified from the Las Vegas Grand Prix after both their cars were found not to comply with technical regulations.
Post-race, the rearmost skid wear on both McLaren MCL39 machines was…

McLaren drivers Lando Norris and Oscar Piastri have been disqualified from the Las Vegas Grand Prix after both their cars were found not to comply with technical regulations.
Post-race, the rearmost skid wear on both McLaren MCL39 machines was…

Again and again, teenage Afghan refugee Soraya Akhalaghi refers to herself and her fellow displaced migrants as “playing a game.” Only some way into “A Fox Under a Pink Moon” — a candid and urgent documentary about her years-long…

Mercedes’ Doriane Pin won the F1 Academy title on Sunday, beating Ferrari’s Maya Weug to the trophy with a fifth-placed finish at the final race of the season in Las Vegas.
Pin came into the season-finale needing at least a top six finish after…

Amazon’s Black Friday event continues to spotlight professional camera gear. Following our recent coverage in Canon Black Friday Deals on Amazon 2025, Nikon Black Friday Deals on Amazon 2025, and Sony Alpha 7 IV Kit Black Friday Amazon…
Pritt, B. S. & Aubry, M. C. Histopathology of viral infections of the lung. Semin. Diagn. Pathol. 34, 510–517 (2017).
Torres, A. et al. Pneumonia. Nat. Rev. Dis. Prim. 7, 25 (2021).

HONOLULU — The University of Hawai’i women’s…

Ruairidh MaciverBBC Naidheachdan
Getty ImagesEighty years ago a small crowd gathered in a hall in Tobermory on Mull for a preview…

Investors who take an interest in Bridgepoint Group plc (LON:BPT) should definitely note that the Independent Non-Executive Director, Cyrus Russi Taraporevala, recently paid UK£2.84 per share to buy UK£284k worth of the stock. That certainly has us anticipating the best, especially since they thusly increased their own holding by 100%, potentially signalling some real optimism.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.
Notably, that recent purchase by Cyrus Russi Taraporevala is the biggest insider purchase of Bridgepoint Group shares that we’ve seen in the last year. That means that an insider was happy to buy shares at above the current price of UK£2.72. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it’s very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was Cyrus Russi Taraporevala.
The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Check out our latest analysis for Bridgepoint Group
Bridgepoint Group is not the only stock insiders are buying. So take a peek at this free list of under-the-radar companies with insider buying.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Based on our data, Bridgepoint Group insiders have about 0.1% of the stock, worth approximately UK£2.3m. We do note, however, it is possible insiders have an indirect interest through a private company or other corporate structure. We prefer to see high levels of insider ownership.
It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. While the overall levels of insider ownership are below what we’d like to see, the history of transactions imply that Bridgepoint Group insiders are reasonably well aligned, and optimistic for the future. So these insider transactions can help us build a thesis about the stock, but it’s also worthwhile knowing the risks facing this company. Our analysis shows 3 warning signs for Bridgepoint Group (1 is significant!) and we strongly recommend you look at these before investing.

Oceaneering International (OII) has caught some attention lately as its stock edged higher, gaining about 3% in the latest session. This uptick comes even as the broader energy sector presented mixed signals for investors.
See our latest analysis for Oceaneering International.
Oceaneering International’s recent share price gain builds on a gradually improving short-term trend, but momentum is still muted compared to last year’s performance. While the stock is up 3.29% in the last session, the one-year total shareholder return sits at -19.58%. This reminds investors of some lingering caution, even after impressive multi-year gains.
If you’re keeping an eye on shifts in energy sector momentum, now is the perfect chance to broaden your search and discover fast growing stocks with high insider ownership
With shares staging a modest rebound, the question now is whether Oceaneering International remains undervalued with more upside ahead, or if investors have already factored in future growth prospects at current levels.
At $24.15 per share, Oceaneering International trades just above the consensus narrative fair value of $22.38, suggesting that the market anticipates robust operational progress and stable growth prospects.
The company’s high dependency on cyclical offshore oil and gas spending, evident in bookings and utilization guidance, makes its revenues and earnings vulnerable to potential sharp downturns if energy prices fall or if capital expenditure plans of major clients decline, as indicated by flat book-to-bill ratios and conservative utilization outlooks.
Read the complete narrative.
What hidden numbers are driving analyst models this time? The narrative is based on detailed assumptions about future revenue streams, margin pressures, and strategic pivots that could change profits more rapidly than many anticipate. Want to know what financial forecasts are influencing this price target? Find out what could surprise investors by reading the full breakdown.
Result: Fair Value of $22.38 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, continued growth in aerospace and defense contracts, or persistent strength in high-margin robotics, could boost earnings beyond current expectations.
Find out about the key risks to this Oceaneering International narrative.
While the market sees Oceaneering International as slightly overvalued based on analyst price targets, our DCF model presents a very different story. The SWS DCF model estimates fair value at $51.12, which is more than double the current share price. This suggests considerable undervaluation. Could analysts be overlooking hidden future cash flows?